SC
BNTX icon

SummitTX Capital’s BioNTech BNTX Stock Holding History

SummitTX Capital’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$335K Buy
+3,600
New +$339K 0.01% 656
2025
Q2 		– Sell
-5,366
Closed -$489K – 762
2025
Q1 		$489K Buy
+5,366
New +$601K 0.02% 560

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

SummitTX Capital's BNTX Position: Q2 2026 in Review

SummitTX Capital opened a new position in BioNTech (BNTX) in Q2 2026: 3,600 shares worth $335K. The stake represents 0.01% of the portfolio and ranks #656 among its holdings. This is a return to the name: SummitTX Capital previously reported a position in BNTX as recently as Q1 2025.

SummitTX Capital first reported a position in BNTX in Q1 2025 and has held it in 2 quarters since. The position peaked at $489K in Q1 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • SummitTX Capital held 3,600 shares of BioNTech worth $335K as of Q2 2026.
  • BioNTech was a new SummitTX Capital position in Q2 2026.
  • BioNTech made up 0.01% of SummitTX Capital's portfolio in Q2 2026, its #656 holding.
  • SummitTX Capital first reported a position in BioNTech in Q1 2025 and has held it in 2 quarters since.
  • SummitTX Capital's BioNTech position peaked at $489K in Q1 2025.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.